Novelty Nobility Inc.

Private

Seongnam-siHealthcare & Life Scienceshttps://www.noveltynobility.com/

Last Round

Series C

Nov 11, 2024

Est. Valuation

$89.74M

Total Funding Raised

$53.27M

Company Overview

Novelty Nobility Inc. is a biotechnology company that specializes in the design, discovery, and development of next-generation antibody therapeutics, including monoclonal antibodies, bispecific antibodies, and antibody-drug conjugates for oncology and immunology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

antibody-drug conjugatesADCmonoclonal antibodiesbispecific antibodiesantibody discoverybiotechdrug developmentoncology therapeuticsbiologicsretinal diseaselinker technologyclinical-stage biotechtherapeutic designdrug licensingbiotech pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Novelty Nobility Inc. Comps

Public and private peers based on sector, stage, and business model.

Novelty Nobility Inc. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Novelty Nobility Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series C	Nov 11, 2024
Series B	May 16, 2022
VC Round	Mar 1, 2021
Series A	Jan 31, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Arlo McGinn

Chief Operating Officer

Executive Team

Novelty Nobility Inc. Investors

Notable investors and investment history

Novelty Nobility Inc. investors
Investor	Rounds
KDB Capital Corp	Series C
K2 Investment Partners	VC Round
Shinhan Venture Investment	Series C, Series A
SL Investment	Series B, Series C
Ulmus Investment	Series A
QUAD Investment Management	Series A
NH Investment & Securities	Series B

View all Investors

Novelty Nobility Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Novelty Nobility Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Novelty Nobility Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSeongnam-si

Employee Range10

Year Founded2017

Last FundingNov 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.